Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-07-28 to 2023-07-31
Current total value of award: $7571.6
Description: 4561635490!NUCALA 100 MG/ML SYRINGEML